Table 5 Determination of RIB in its pharmaceutical formulations by the proposed method and statistical comparison with a reported HPLC method
Pharmaceutical formulation | Equivalent concentration of analytes (µg/mL) | % Recoverya by the developed method ± SD | Claimed amount (mg) | % Recoverya by the reported methods ± SD | t-testb | F-testb |
|---|---|---|---|---|---|---|
Ribavirin® capsules (200.00 mg) | 4.00 | 102.81 ± 0.64 | 205.62 | 103.69 ± 1.09 | 1.70 | 2.87 |